References
- SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
- YangLZhangBXingGNeoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: A meta-analysis of peri-operative outcomePLoS One20171210e018672529059209
- WalshCTargeted therapy for ovarian cancer: the rapidly evolving landscape of PARP inhibitor useMinerva Ginecol201870215017028994564
- HamiltonCAMillerACasablancaYClinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data studyGynecol Oncol2018148227528029195926
- McguireWPMarkmanMPrimary ovarian cancer chemotherapy: current standards of careBr J Cancer200389Suppl 3(Suppl 3)S3S8
- LynchHTCaseyMJLynchJWhiteTEGodwinAKGenetics and ovarian carcinomaSemin Oncol19982532652809633840
- LlauradóMAbalMCastellvíJETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cellsInt J Cancer201213071532154321520040
- YuanHKajiyamaHItoSALX1 induces snail expression to promote epithelial-to-mesenchymal transition and invasion of ovarian cancer cellsCancer Res20137351581159023288509
- HeSNiuGShangJThe oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathwayJ Exp Clin Cancer Res201736113728978336
- LaiFFernaldAAZhaoNLe BeauMMcDNA cloning, expression pattern, genomic structure and chromosomal location of RAB6KIFL, a human kinesin-like geneGene20002481–211712510806357
- ShiCHuangDLuNAberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosisOncotarget2016718262062621927036048
- HoJRChapeaublancEKirkwoodLDeregulation of Rab and Rab effector genes in bladder cancerPLoS One201276e3946922724020
- ClaerhoutSLimJYChoiWGene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancerPLoS One201169e2466221931799
- YamashitaJFukushimaSJinninMKinesin family member 20A is a novel melanoma-associated antigenActa Derm Venereol201292659359722854760
- ZouJXDuanZWangJKinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistanceMol Cancer Res201412453954924391143
- Nestal de MoraesGJiZFanLYSUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cellsOncogenesis2018732929540677
- StangelDErkanMBuchholzMKIF20A inhibition reduces migration and invasion of pancreatic cancer cellsJ Surg Res201519719110025953216
- GasnereauIBoissanMMargall-DucosGKIF20A mRNA and its product MKlp2 are increased during hepatocyte proliferation and hepatocarcinogenesisAm J Pathol2012180113114022056911
- JanuchowskiRSterzynskaKZawieruchaPMicroarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell linesOncotarget2017830499444995828611294
- HennessyBTColemanRLMarkmanMOvarian cancerLancet200937496981371138219793610
- WeiWBirrerMJSpleen tyrosine kinase confers paclitaxel resistance in ovarian cancerCancer Cell20152817926175410
- KhongkowPGomesARGongCPaclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistanceOncogene2016358990100225961928
- KlymenkoYKimOLoughranECadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasisOncogene201736425840585128628116
- YeYYinMHuangBWangYLiXLouGCLIC1 a novel biomarker of intraperitoneal metastasis in serous epithelial ovarian cancerTumour Biol20153664175417925582317
- PengFZhongYLiuYSPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinomaInt J Oncol20175161920192829075785
- di ReFBaiocchiGFontanelliRSystematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastasesGynecol Oncol19966233603658812533
- ConcinNHeflerLvan BavelJBiological markers in pT1 and pT2 ovarian cancer with lymph node metastasesGynecol Oncol200389191512694648
- ElsnerovaKBartakovaATihlarikJGene expression profiling reveals novel candidate markers of ovarian carcinoma intraperitoneal metastasisJ Cancer20178173598360629151946
- AyhanAGultekinMTaskiranCLymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variablesGynecol Oncol200597240040415863136
- NoordhuisMGFehrmannRSWismanGBInvolvement of the TGF-beta and beta-catenin pathways in pelvic lymph node metastasis in early-stage cervical cancerClin Cancer Res20111761317133021385933
- ZhangDLiBShiJSuppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion proteinCancer Res20107062495250320197464
- FengJZhangYXingDLow-power laser irradiation (LPLI) promotes VEGF expression and vascular endothelial cell proliferation through the activation of ERK/Sp1 pathwayCell Signal20122461116112522326662
- LiXGuFNiuCVEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growthJ Transl Med20151316425990504
- ZhangWXiongZWeiTNuclear factor 90 promotes angiogenesis by regulating HIF-1α/VEGF-A expression through the PI3K/Akt signaling pathway in human cervical cancerCell Death Dis20189327629449553
- GengJLiXZhouZWuCLDaiMBaiXEZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancerCancer Lett2015359227528725633838
- ChenLXiaoHWangZHmiR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-ABMB Rep2014471394424209632
- ExertierPJaverzatSWangBImpaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5Oncotarget20134122302231624327603
- AsaharaSTakedaKYamaoKMaguchiHYamaueHPhase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancerJ Transl Med20131129124237633
- AlipourSZoghiSKhaliliNHirbod-MobarakehAEmensLARezaeiNSpecific immunotherapy in ovarian cancer: a systematic reviewImmunotherapy20168101193120427605068
- TomitaYYunoATsukamotoHIdentification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumorClin Cancer Res201319164508452023714729
- DingZCZhouGCytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effectsClin Dev Immunol201220128901781222400040
- LesterhuisWJHaanenJBPuntCJCancer immunotherapy-revisitedNat Rev Drug Discov201110859160021804596
- WalterSWeinschenkTStenzlAMultipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survivalNat Med20121881254126122842478